Condition (MeSH)
Sacroiliitis
ClinicalTrials.gov lists 34 trials for Sacroiliitis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
34 of the 34 trials are tagged with Sacroiliitis itself; the rest are tagged with a narrower condition beneath it.
When did Sacroiliitis trials start? (15)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 5 |
| 2022 | 4 |
| 2021 | 2 |
| 2020 | 1 |
| 2019 | 3 |
| 2018 | 2 |
| 2017 | 2 |
Showing 10 of 15 earlier years.
No forecast is made for this condition: it averages 3.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 32 months from start to primary completion across 5 trials still running at the 2026-10-09 snapshot; registered median of 20 months across 18 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Sacroiliitis trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 2 |
| Phase 4 | 2 |
| Not applicable | 19 |
| Observational | 9 |
How many Sacroiliitis trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Completed | 17 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Sacroiliitis trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| FUSMobile Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| AbbVie (prior sponsor, Abbott) | 1 |
| CornerLoc | 1 |
Which drugs are being tested for Sacroiliitis? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| IOHEXOL | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| [PRP] platelet rich plasma | 2 |
| sacroiliac joint injection | 2 |
| Secukinmab | 2 |
| Adalimumab-US | 1 |
| Steroid (dexamethasone) Injection | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Sacroiliitis trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| ABDOMINAL PAIN UPPER | 2 | 1 |
| Abdominal pain | 2 | 1 |
| Cellulitis | 2 | 1 |
| Colitis ulcerative | 2 | 1 |
| HEADACHE | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Sacroiliitis? (37)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study. | Clinical and experimental rheumatology | 2023 | Yes |
| Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial. | The Journal of rheumatology | 2023 | Yes |
| Evaluation of the agreement between the ACR 1990 fibromyalgia tender points and an enthesitis score in patients with axial spondyloarthritis. | Rheumatology (Oxford, England) | 2023 | Yes |
| Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis. | Arthritis research & therapy | 2023 | Yes |
| The prevalence of sacroiliitis on abdominal MRI examinations of patients with Takayasu arteritis. | Acta radiologica (Stockholm, Sweden : 1987) | 2022 | Yes |
Showing 5 of 37 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.